Literature DB >> 26489423

The effect of EGB on proliferation of gastric carcinoma SGC7901 cells.

Y Qian1, L Xia2, W Shi1, J J Sun1, Y Q Sun3.   

Abstract

OBJECTIVE: To investigate the effect of Ginkgo biloba extract (EGB) on the proliferation and cell cycles of gastric carcinoma SGC7901 cells, and make a preliminary exploration on possible molecular mechanisms associated with its inhibitory effect.
METHODS: Human gastric carcinoma SGC7901 cells were cultured in vitro, and treated with various concentrations (100, 200, 300, 400 mg/L) of EGB for different incubation periods (24, 48 and 72 h). CCK-8 assay was used to detect cell proliferation and flow cytometry was performed to analyze the effect of EGB on cell cycles. In addition, mRNA and protein level of two cell cycle regulators cyclin D1 and c-myc in SGC7901 cells treated with EGB were determined using PCR and Western blot. And subcutaneous xenograft model of gastric carcinoma in nude mice was established to evaluate the anti-cancer effect of EGB in vivo.
RESULTS: The proliferation of gastric carcinoma SGC7901 cells was inhibited by EGB in dose- and time-dependent manner. Flow cytometry showed cell cycle arrest in EGB-treated cells, with increased percentage of cells in G1 phase and decreased percentage in S stage. In addition, the mRNA and protein level of cyclin D1 and c-myc genes were significantly down-regulated in cells with EGB treatment with the concentration increasing.
CONCLUSION: EGB conferred an inhibitory effect on the proliferation of gastric carcinoma SGC7901 cells both in vitro and in vivo. The inhibitory effect was dose dependent and possibly depended on inhibiting cell cycle through G1 arrest induction by suppressing cyclin D1 and c-myc expression.

Entities:  

Keywords:  Cell proliferation; EGB; Gastric carcinoma

Mesh:

Substances:

Year:  2015        PMID: 26489423     DOI: 10.1007/s12094-015-1399-3

Source DB:  PubMed          Journal:  Clin Transl Oncol        ISSN: 1699-048X            Impact factor:   3.405


  24 in total

1.  Ginkgo biloba extract (EGb 761) induces apoptosis by the activation of caspase-3 in oral cavity cancer cells.

Authors:  Kyung-Su Kim; Kwang-Hyeon Rhee; Joo-Heon Yoon; Jeung Gweon Lee; Joo-Hwan Lee; Jong-Bum Yoo
Journal:  Oral Oncol       Date:  2005-04       Impact factor: 5.337

2.  Cardiovascular autonomic neuropathy in spontaneously diabetic rats with and without application of EGb 761.

Authors:  Rick Schneider; Klaus Welt; Wolfram Aust; Regina Kluge; Heinz Löster; Günther Fitzl
Journal:  Histol Histopathol       Date:  2010-12       Impact factor: 2.303

3.  Phase II study of combined 5-fluorouracil/ Ginkgo biloba extract (GBE 761 ONC) therapy in 5-fluorouracil pretreated patients with advanced colorectal cancer.

Authors:  B Hauns; B Häring; S Köhler; K Mross; C Unger
Journal:  Phytother Res       Date:  2001-02       Impact factor: 5.878

4.  Oxidative Stress and C-Reactive Protein in Patients with Cerebrovascular Accident (Ischaemic Stroke): The role of Ginkgo biloba extract.

Authors:  Imad A-J Thanoon; Hilmy As Abdul-Jabbar; Dhia A Taha
Journal:  Sultan Qaboos Univ Med J       Date:  2012-04-09

5.  [Ginkgo biloba extracts (EGb761) inhibits aflatoxin B1-induced hepatocarcinogenesis in Wistar rats].

Authors:  Yan-rong Hao; Fang Yang; Ji Cao; Chao Ou; Jing-jing Zhang; Chun Yang; Xiao-xian Duan; Yuan Li; Jian-jia Su
Journal:  Zhong Yao Cai       Date:  2009-01

6.  Ginkgo biloba extract (EGb 761) protects against cisplatin-induced ototoxicity in rats.

Authors:  Xinyan Huang; Craig A Whitworth; Leonard P Rybak
Journal:  Otol Neurotol       Date:  2007-09       Impact factor: 2.311

7.  Ginkgo biloba extract kaempferol inhibits cell proliferation and induces apoptosis in pancreatic cancer cells.

Authors:  Yuqing Zhang; Aaron Y Chen; Min Li; Changyi Chen; Qizhi Yao
Journal:  J Surg Res       Date:  2008-03-26       Impact factor: 2.192

8.  Reduction of atherosclerotic nanoplaque formation and size by Ginkgo biloba (EGb 761) in cardiovascular high-risk patients.

Authors:  M Rodríguez; L Ringstad; P Schäfer; S Just; H W Hofer; M Malmsten; G Siegel
Journal:  Atherosclerosis       Date:  2007-03-29       Impact factor: 5.162

9.  [Effect of extract of Ginkgo biloba on doxorubicin-associated cardiotoxicity in patients with breast cancer].

Authors:  Shan-Yong Yi; Ke-Jun Nan; Sheng-Jie Chen
Journal:  Zhongguo Zhong Xi Yi Jie He Za Zhi       Date:  2008-01

10.  Effects of EGb 761 on nitric oxide and oxygen free radicals, myocardial damage and arrhythmia in ischemia-reperfusion injury in vivo.

Authors:  J Shen; J Wang; B Zhao; J Hou; T Gao; W Xin
Journal:  Biochim Biophys Acta       Date:  1998-04-28
View more
  4 in total

1.  Ginkgo biloba induces different gene expression signatures and oncogenic pathways in malignant and non-malignant cells of the liver.

Authors:  Carolin Czauderna; Mayrel Palestino-Dominguez; Darko Castven; Diana Becker; Luis Zanon-Rodriguez; Jovana Hajduk; Friederike L Mahn; Monika Herr; Dennis Strand; Susanne Strand; Stefanie Heilmann-Heimbach; Luis E Gomez-Quiroz; Marcus A Wörns; Peter R Galle; Jens U Marquardt
Journal:  PLoS One       Date:  2018-12-21       Impact factor: 3.240

Review 2.  Ginkgo biloba: A Treasure of Functional Phytochemicals with Multimedicinal Applications.

Authors:  Rajib Das; Mashia Subha Lami; Arka Jyoti Chakraborty; Saikat Mitra; Trina Ekawati Tallei; Rinaldi Idroes; Amany Abdel-Rahman Mohamed; Md Jamal Hossain; Kuldeep Dhama; Gomaa Mostafa-Hedeab; Talha Bin Emran
Journal:  Evid Based Complement Alternat Med       Date:  2022-02-28       Impact factor: 2.629

Review 3.  Advances in the Studies of Ginkgo Biloba Leaves Extract on Aging-Related Diseases.

Authors:  Wei Zuo; Feng Yan; Bo Zhang; Jiantao Li; Dan Mei
Journal:  Aging Dis       Date:  2017-12-01       Impact factor: 6.745

4.  Ginkgo Biloba Extract Inhibits Metastasis and ERK/Nuclear Factor kappa B (NF-κB) Signaling Pathway in Gastric Cancer.

Authors:  Zhenhua Fu; Lan Lin; Shiquan Liu; Mengbin Qin; Siwei He; Liye Zhu; Jiean Huang
Journal:  Med Sci Monit       Date:  2019-09-11
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.